London, England and Lugano, Switzerland 19 November 2019 – Accord Healthcare Limited (“Accord”) and ADIENNE Pharma & Biotech S.A. (“ADIENNE”) have entered into an exclusive licencing and distribution agreement for the commercialisation of TEPADINA® (thiotepa) 15mg and 100mg lyophilized powder for injections.
We are delighted to announce that Accord Healthcare was the most recognised company at the Global
Accord Healthcare war bei den diesjährigen Global Generics & Biosimilars Awards am 23. Oktober 2017 gleich in mehreren Kategorien in der engeren Auswahl.
Intas Pharmaceuticals completes deal to acquire Actavis UK & Ireland generics businesses.